China: A recent study published in the Annals of Hepatology has emphasized the influence of age on hepatocellular carcinoma ...

A new study shows that artificial intelligence (AI) can help doctors make better decisions when treating cancer. However, it also highlights challenges in how doctors and AI work together. The study ...

Fujifilm Middle East and Africa, part of the globally renowned Fujifilm Corporation, participates at Arab Health 2025, taking ...

A new study led by researchers from Moffitt Cancer Center, in collaboration with investigators from the University of ...

Empowering medical professionals with the latest imaging technologies in early screening, detection, and diagnostics ...

Fujifilm Middle East and Africa part of the globally renowned Fujifilm Corporation is participating at Arab Health 2025 ...

Worldwide, hepatitis B virus is the major risk factor for hepatocellular carcinoma (HCC), owing to its high prevalence in the developing world. Hepatitis B virus vaccination programs have and will ...

The American Gastroenterology Association (AGA) issued a new clinical guideline recommending antiviral drugs for patients at high risk for hepatitis B reactivation. (Gastroenterology) Researchers ...

"To our knowledge, our study represents the first randomized, global study to report data for an anti-TIGIT monoclonal antibody in hepatocellular carcinoma," Finn and colleagues wrote in Lancet ...

Despite technical improvements in all modes of HCC diagnostic imaging, difficulties remain in accurately identifying small (< 2 cm) lesions on the background of cirrhosis in all imaging modalities.

1The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York. 2Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.